Quentis Therapeutics

About:

Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.

Website: http://www.quentistx.com/

Twitter/X: QuentisTx

Top Investors: Alexandria Venture Investments, AbbVie, Polaris Partners, Versant Ventures, New York Ventures

Description:

Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.

Total Funding Amount:

$49M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2016-01-01

Contact Email:

Info(AT)quentistx.com

Founders:

Juan Cubillos-Ruiz, Laurie Glimcher, Sarah Bettigole

Number of Employees:

11-50

Last Funding Date:

2018-12-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai